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We review the medical literature on the success, safety and economic value of central neuraxial blockade-assisted (CNB) external
cephalic version from randomized controlled studies identiﬁed from 1951 to 2009. The result showed that more women had
successful ECV with regional anaesthesia with corresponding reduction in caesarean section rate. They were 1.5 times more likely
than women not receiving anaesthesia to have a successful ECV. The number to treat is six women needed to receive anaesthesia
for 1 baby to be turned from breech to cephalic presentation. Feto-maternal morbidity was not increased in the CNB-aided group
consisting of only transient bradycardia. Although the appropriate amount of force for safe version has not been quantiﬁed, there
was no report of uterine rupture despite removal of these patients from “excessive force-pain biofeedback loop” induced through
motor nerve blockade. We can attribute 30% of cost savings amounting to £42,150.00 directly to CNB using the most up to date
Health Resource Group Code (HRG4). The initial results are encouraging but until the beneﬁts and safety of CNB-aided ECV are
substantiated by large randomized, blinded controlled trials, this practice cannot be universally recommended.
Copyright © 2009 I. Bolaji and L. Alabi-Isama. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The problem of rising caesarean section is one of paramount
importance and continues to be of increasing interest and
concern. This increase is not limited to Europe [1]b u tgl o b a l
[2] and although this increase involves principally the lower
segment procedure, classical caesarean section has not been
excluded [3]. Despite the growing national and international
trend some units still maintain a relatively low caesarean
section rate (CSR) (Table 1).
One suggested reason for the rise is increasing requests
by women for caesarean section (CS) in the absence of clear
medical indications such as placenta praevia and arguably,
breech presentation, or previous caesarean section [4, 5].
Several authors have suggested a number of strategies
for reducing CSR [1, 6–8], particularly “primary C-section,”
including external cephalic version (ECV). Turning the fetus
to the cephalic/vertex position by external manipulation
has been identiﬁed as the only clinical intervention with
demonstrated grade A evidence of reducing CS overall [6].
Approximately 4% of term singleton babies present as
a breech [9]. This accounts for nearly 20% of primary CS
and this rate is rising [1]. This increase is partly due to
“defensive obstetrics” and has been more dramatic following
the publication of the term breech trial [10]. Consequently,
a trial of ECV at term has become increasingly popular.
The majority of women would prefer a vaginal birth (VB)
[11] although most would choose CS if there is a medical
indication [12]. For single fetus in breech presentation,
CS has been shown to be safer for the fetus than VB
[10, 13] and the majority now recommend CS for term
breech presentation [14]. Although the risks associated with2 Obstetrics and Gynecology International
Table 1: Eight-year review of caesarean sections-Diana, Princess of Wales Hospital, Grimsby UK⊥.
Year Deliveries Babies Caesarean section Emergency C-section⊥ Elective C-section⊥⊥
N%N % N %
5-Year review∗
2001 1951 1979 362 18.60% 203 11% 159 8%
2002 1973 1992 344 17.40% 194 10% 150 8%
2003 2069 2106 387 18.70% 221 11% 166 8%
2004 2235 2261 405 18.10% 238 11% 167 8%
2005 2350 2384 387 16.40% 258 11% 129 6%
Total 10578 10722 1885 17.84% 1114 10.80% 771 7.60%
8-Year review∗∗
2006 2420 2458 413 17.10% 233 10% 180 8%
2007 2458 2535 450 18.10% 240 10% 210 8%
2008 2508 2577 415 16.30% 213 8% 202 3%
Total 17964 18292 3163 17.59% 1800 10.25% 1363 7.13%
⊥Diana, Princess of Wales Hospital, Grimsby serves a fairly stable predominantly working class population of about 91000 in the Northeast Lincolnshire, UK.
⊥⊥C-Section-Lower segment caesarean section. ∗Five-year review was from January 1, 2001 to December 31, 2005. ∗∗ Eight-year review was from January 1,
2001 to December 31, 2008.
operative delivery are low, it is not without fetomaternal
incidents and CS remains the largest contributing factor to
the incidence of maternal morbidity and mortality in the
pueperium [15]. Operative delivery quadruples the risk of
severe morbidity compared to VB [16–18].
TherationaleforECVistoreducetheincidenceofbreech
presentation at term, the associated risks of vaginal breech
delivery, and also the risk of avoidable caesarean section [7].
SuccessratesforECVhavebeenvariable,rangingfrom35%–
86% with an average of 58%, and a number of strategies have
been proposed to improve this, thereby reducing the CSR.
Tocolytics have been used in this regard in the last three
decades [19], with initial studies reporting success rates
of about 60%–80% [19, 20]. Terbutaline was found to be
the most commonly used beta-sympathomimetic agent to
achieve tocolysis prior to ECV.
A recent Cochrane Database of systemic reviews on
interventions to help ECV concluded that routine tocolysis
appears to reduce the failure rate of ECV at term [21].
Although the reduction of noncephalic presentations at
birth was not statistically signiﬁcant, there was, however, a
reduction in the number of CSs [21].
Nonmedical interventions to improve spontaneous ver-
sion rate have been described by several authors. They
include postural techniques, entailing relaxation with the
pelvis in an elevated position (knee-chest position assumed
with full bladder) [22], “Indian Version” [23], Vibroacoustic
stimulation for midline spine position [24], transabdominal
amnioinfusion with warmed saline [25], acupuncture [26],
and complementary medicine in form of moxibustion. The
latter is a traditional Chinese medicine involving the burning
of a herb, Artemisia vulgaris, close to the skin to induce
warming sensation [27]. There is, however, insuﬃcient evi-
dencetosupportthesemethods.Otheralternativesincluding
the use of hypnosis and acupuncture or moxibustion to the
acupuncture point bladder 67 (BL67), located at the tip of
the ﬁfth toe [26], have been poorly researched. A recent
randomized controlled trial on moxibustion for breech
version [27] showed no beneﬁcial eﬀect. Despite this lack
of proven eﬀectiveness, women had positive opinions of the
intervention.
2. Method
This paper reviews the medical literature to determine the
success, safety, and economic value of regional anaesthesia-
assisted ECVs.
The inclusion criteria include clinical trials evaluating
ECVsuccessusingbothrandomizedandnonrandomizedtri-
als. The interventions studied were all methods of maternal
anaesthesia including general anaesthetic, central neuraxial
anaesthesia (CNB), or analgesia used to aid ECV.
The primary outcome was the proportion of participants
with a successful external cephalic version at the end of the
attempts. Secondary outcomes included fetal presentation at
delivery, method of delivery, fetal morbidity and mortality,
and maternal morbidity.
Articles were identiﬁed in searches using the follow-
ing electronic databases: MEDLINE (MEDLARS OnLine),
Cochrane, and RCOG using DIALOG Information Retrieval
Service covering the period 1960–2009 under the following
medical subject heading key words: external cephalic version
and anaesthesia or analgesia in either the heading or text
words.
Hand searches of the articles identiﬁed within references
w e r ec o n d u c t e da sw e l la ss e a r c h e sf r o mt h eI n t e r n a t i o n a l
Journal of Obstetric Anaesthesia and the published abstracts
of the annual meetings of the American Society of Anaesthe-
siologists and the Canadian Anaesthesia Society. All attempts
were made to identify relevant data on this topic.
Two reviewers (L. AI and I. IB) inspected titles and
abstracts of all the references retrieved from the search to
select all potentially relevant studies. Studies that met the
inclusion criteria were categorized. Each potentially relevantObstetrics and Gynecology International 3
study was then reviewed to identify randomized control
trials.
Results from the randomized trials were combined using
random eﬀects model. The primary outcome which is
successful ECV was expressed in relative risk (RR) with
95% conﬁdence intervals. An RR of greater than 1.0 would
indicate the proportion of women with successful ECV
with anaesthesia over those without anaesthesia. Statistical
signiﬁcance was deﬁned as a P value <.05 and if the
95% conﬁdence interval (CI) did not include 1.0. Numbers
needed to treat (NNT) are the inverse of the Absolute Risk
Reduction (NNT = 1/ARR) and absolute risk reduction
(ARR) is the experimental event rate-control event rate.
Twenty nine studies were identiﬁed from initial literature
search and reviewed. The articles ranged in publication from
1951 to 2009. Of these, 22 were nonrandomized prospective
and retrospective studies. Only seven articles were random-
ized controlled trials including two studies comparing the
use of epidural anaesthesia [28, 29] with no anaesthesia, four
studies compared the use of spinal anaesthesia [30–33]w i t h
noanaesthesia,andonestudycomparedtheuseofcombined
spinal and epidural anaesthesia [34] with no anaesthesia. Six
of the 7 studies were conducted in the US, the seventh study
was conducted in Israel, and all seven studies were published
between 1997 and 2009. The study by Delisle et al. [32]w a s
published in abstract form with limited study information
available. There were 681 women participating in the seven
studies with 339 women receiving either epidural or spinal
anaesthesia, 47 women receiving intravenous fentanyl, and
295 receiving no anaesthetic.
3. Effectivenessof Central
NeuraxialBlockade-AssistedExternal
CephalicVersion
There has been renewed interest in the practice of central
neuraxial blockade-assisted ECV at term especially in the
USA. Central neuraxial blocks are a group of anaesthetic
techniques which include epidurals, spinals, and combined
spinal epidurals (CSEs). All are invasive techniques involving
injection of pain relieving drugs into the vertebral canal
(spinal) and epidural space (epidural) and requiring a needle
to be placed close to the central nervous system. CNB has the
potential to provide patients with optimal pain relief but can
also lead to patient harm. The 3rd National Audit Project of
the Royal College of Anaesthetists [35] provides reassuring
results for the use of this technique.
It is known that ECV does not currently play a signiﬁcant
role in the management of breech presentation and that
epidural-assisted ECV might improve success rates. Preterm
ECV is a subject of an ongoing international multicentre
randomized study [36] and is not considered in this review.
ECV is at the very least uncomfortable, if not overtly
painful and is associated with maternal anxiety. Maternal
discomfort and anxiety are associated with higher rates of
failure of ECV and for that reason regional anaesthesia
has been proposed to facilitate ECV. The rationale for the
inclusion is that whilst tocolytic agent provides uterine
relaxation, CNB provides abdominal muscular relaxation
through motor nerve block hence its eﬀects on maternal
pain, muscle tone, and anxiety. General anaesthesia has been
used in the past for ECV but was abandoned following
reports of fetal mortality, which in some series reached 1%
[37].
A retrospective study in the setting of previously failed
ECV attempts by Cherayil et al. [31] showed that the success
rates in nulliparous women reattempted with spinal and
epidural anaesthesia were 4/5 (80%) and 5/6 (83%), respec-
tively. Success rates in multiparous women reattempted with
spinal and epidural anaesthesia were 1/1 (100%) and 3/3
(100%) (P = NS). High ECV success rates were noted
in nulliparous (9/11 [82%]) and multiparous (4/4 [100%]
(P = .36) women, respectively. Overall, 8/9 (89%) and 5/6
(83%) (P = NS) ECV attempts were successful with epidural
and spinal anaesthesia, respectively.
In a retrospective cohort study by Carlan et al. [38], ECV
at term was successful in 59% of 32 women with epidural
analgesia, and 24% of 37 women without anaesthesia. Albeit
a retrospective analysis and limited as well by a relatively
small number of patients, the study shows an encouraging
increase in the success rate for ECV performed with epidural
analgesia. This is an impressive diﬀerence, because in the
epiduralgrouptherewererelativelymoreversionsperformed
by nonconsultant grade and more patients with advanced
cervical dilatation or even in labour. Both of these factors
would be expected to decrease success in the study group.
In addition, of the 28 patients who failed a ﬁrst attempt
at version without anaesthesia, 7 patients had successful
versions when a second attempt was performed with CNB.
In an uncontrolled study, ECV under epidural analgesia
was successful in nine (56%) of 16 women in whom initial
attempts had failed [39, 40]
Several randomized controlled trials have compared the
use of regional anaesthesia with no anaesthesia before per-
forming ECV. Weiniger et al. [30], in a randomized control
trial of ECV using regional anaesthesia amongst nulliparous
women showed that ECV was more successful in the women
who were randomized to receive spinal anaesthesia (24 of
36 [66.7%] compared with 11 of 34 [32.4%], who did not
receive spinal anaesthesia (P = .04). Fifteen women in
the control group had unsuccessful version due to pain
that did not allow a suﬃcient ECV attempt and all ﬁfteen
were oﬀered subsequent spinal anaesthesia. Eleven of them
had successful ECV under spinal anaesthesia. Sullivan et al.
[34] randomized 48 women to receive combined spinal
and epidural anaesthesia (CSE) and 47 women to receive
intravenous fentanyl (SYS) and showed that a success rate of
ECVwas47%withCSEand31%intheSYSgroup(P = .14).
There was no diﬀerence in the rate of successful ECV or
vaginal delivery with CSE compared to intravenous fentanyl
analgesia. Pain scores were lower and satisfaction higher with
CSE analgesia, and median time to fetal heart rate reactivity
was shorter in the CSE group.
A meta-analysis by Marcarthur et al. [41]c o m p a r e df o u r
prospective randomized studies measuring the success rate
of ECV performed using neuraxial analgesia and described
an overall success rate of 50%. They found that more women4 Obstetrics and Gynecology International
Table 2: Success rates of central neuraxial block-aided ECV-discordant randomized trials.
Study ∗Gestational age Treatment (%) Control (%) RR (95% CI)
EPIDURAL
Schorr et al. [29] >37 weeks 24/35 (68.6) 11/34 (32.4) 2.12 (1.24, 3.62)
Mancuso et al. [28] >37 weeks 32/54 (59.3) 18/54 (33.3) 1.78 (1.15, 2.75)
Total 89 88 1.90 (1.38, 2.64)
SPINAL
Weiniger et al. [30] >37 weeks 24/36 (66.7) 11/34 (32.4) 2.06 (1.25, 3.43)
Dugoﬀ et al. [31] 38 weeks 22/50 (44.0) 22/52 (42.3) 1.04 (0.67, 1.62)
Delisle et al. [32] Unknown 41/99 (41.4) 31/102 (30.4) 1.36 (0.94, 1.98)
Hollard [33] >37 weeks 9/17 (52.9) 10/19 (52.6) 1.01 (0.54, 1.82)
Total 202 207 1.31 (1.04, 1.66)
⊥CSE
Sullivan [34] >36 weeks 22/48 (45.8) 18/47 (38.3) 1.19 (0.74, 1.92)
Overall Total 339 342 1.45 (1.21, 1.72)
∗Gestational age when ECV was performed. ⊥CSE combined spinal and epidural.
had successful ECV if they received regional anaesthesia
(119/238; 50%) compared to women who did not receive
anaesthesia (82/242; 34%).
There was discordance between the trials included in
our review (Table 2). ECV failure was signiﬁcantly reduced
in the two trials using epidural anaesthesia [28, 29]b u tn o
diﬀerence was found in the trial by Dugoﬀ et al. [31]. Schorr
et al. [29] demonstrated a signiﬁcant beneﬁcial eﬀect of
anaesthesia in both primary and secondary outcomes. Only
one women in the control group reverted from a cephalic
version to a breech after successful ECV compared to none
in the anaesthetic group. The number of caesarean sections
in the control group was more than those in the treatment
group. In the study by Macusso et al. [28], there was no
statistical diﬀerence between the groups in gestation at the
time of procedure, placental location, fetal lie, estimated fetal
weight, or amniotic ﬂuid index but ECV was successful in
32 of 54 women (59%) with epidural anaesthesia compared
with 18 of 54 (33%) with no anaesthesia (RR 1.78, 95%
CI 1.15, 2.75, P<. 05). Vaginal delivery occurred in 29
of 54 women (54%) in the treatment group and 16 of 54
women (30%) in the control group (RR 1.81, 95% CI 1.14,
2.92, P<. 05). The study by Weiniger et al. [30] showed
that successful ECV occurred among 24/36 (66.7%) women
randomized to receive spinal analgesia compared with 11 of
34 (32.4%) without anaesthesia (RR 2.06, 95% CI of 1.25,
3.43; P<. 05). This contradicted the spinal study by Dugoﬀ
et al. [31] where there was no statistical diﬀerence between
the anaesthetic {22/50 (44.0%) P = .03} and no anaesthetic
group {(22/52 (42.3%) P = .1}.
4. Safety of CentralNeuraxial
Blockade-Assisted ExternalCephalicVersion
One major concern has traditionally been that if the patient
is removed from “excessive force-pain biofeedback loop,”
then there is potential risk that ECV facilitated by regional
block could lead to use of excessive force. This may result
in increased incidence of abruption, Rh-isoimmunisation,
uterine rupture, cord prolapse, and other serious conditions.
Fetal morbidity was not increased in the group that had
regional anaesthesia consisting only of a transient brady-
cardia (9.9%; 26/263). One attempt in both spinal and
epidural group was associated with fetal bradycardia needing
caesarean section with APGAR scores of 8 and 9 at 1 and 5
minutes, respectively [42]. The outcome of fetal morbidity
was not calculated as there was no fetal or neonatal death.
Although the appropriate amount of force for safe version
hasnotbeenquantiﬁed,therehavebeennoreportsofuterine
rupture during attempted ECV under neuraxial analgesia
(Table 3).
In our unit, we adopt “the rule of 3” which consists of
three criteria for stopping the ECV (Table 4). The procedure
is discontinued if the woman reports undue discomfort, if
the fetal heart tones are nonreassuring or there is unsuccess-
ful version after three manoeuvres.
Stephen Pratt [44, 45] has argued in favour of epidural
use for ECV. He suggested that the use of continuous fetal
monitoring and real time ultrasound scan is now routine
duringECV,allowingthecliniciantocloselymonitormother
and baby, thereby greatly decreasing the risk of catastrophic
events.
On the other hand, there is the risk of epidural
anaesthesia [35] such as dural puncture and headaches,
haematoma, and other neurological complications. One
plausible way of reducing the risk of regional anaesthesia
is to delay this procedure until the onset of established
labour when epidural can be oﬀered for pain relief but
the downside is the membranes may have ruptured already
hence, reducing the success of the ECV attempt. Neu-
raxial anaesthesia can be used selectively in women with
failed attempts or very anxious women in an environment
where Caesarean delivery is immediately possible if the
version fails or signiﬁcant complication occurs monitored by
cardiotocograph.Obstetrics and Gynecology International 5
Table 3: Summary of Central Neuraxial Blockade-Assisted ECV Trials.
Author/Year Type of Study Subjects Success of ECV Complications
Carlan et al. [38] (1994)
Retrospective chart
review at >36
weeks
32 epidural; 37
control
59% success and 54%
vag del; 24% and 21%
in control
7 bradycardia, 1
abruption with
epidural; 2 and 1 in
control
Schorr et al. [29] (1997)
Prospective
randomized at >37
weeks
35 epidural; 34
control
69% success; 66%
vaginal delivery in
epidural group; 32%
and 31% in control
NA
Dugoﬀ et al. [31] (1999) Prospective
randomized
50 spinal; 52
control
44% success in spinal
group; 42% control
11 bradycardia, 4
hypotension with
spinal; 6 bradycardia, 1
abruption, 4 patient
pain in control
Mancuso et al. [28] (2000)
Prospective
randomized at >37
weeks
54 epidural; 54
control
59% success and 54%
vag del in epidural
group; 33% and 30%
in control (P<. 05)
4% bradycardia in
epidural group; 6% in
control
Birnbach et al. [43] (2001) Prospective open at
>36 weeks
20 received
spinal analgesia;
15 did not
80% success in spinal
group; 33% in control
Fetal bradycardia
requiring section in
1 pt. in control group
Delisle et al. [32] (2001) Prospective
randomized
99 spinal; 102
control
41% success in spinal
group; 30% control Unknown
Hollard et al. [33] (2003) Prospective
randomized
17 spinal; 19
control
52.9% success in spinal
group; 52.6% control
1 placenta abruption in
spinal group
Weiniger et al. [30] (2007)
Prospective
randomized at >37
weeks
36 spinal; 34
control
66.7% success in spinal
group; 32.4% control
2 transient bradycardia,
7h y p o t e n s i o n
Sullivan et al. [34] (2009)
Prospective
randomized at ≥36
weeks
22 CSE⊥;1 8I V
fentanyl
45.8% success in CSE
group; 38.3% IV
fentanyl group
1 bradycardia in each
group needing EMCS∗
⊥CSE combined spinal and epidural. ∗EMCS Emergency Caesarean Section.
Table 4: Grimsby ECV rule of three±.
Criteria for stopping external cephalic version (ECV)
1 Undue Maternal Discomfort
2 Non-reassuring Fetal Heart Tones/Patterns
3 Unsuccessful version after three manoeuvres
±ECV is discontinued if one of the above 3 criteria occurs
5. Cost Effectiveness of
CentralNeuraxialBlockade-Assisted
ExternalCephalicVersion
We use the new Health Resource Groups [46] (HRG) for
cost calculation. HRGs are standard groupings of clinically
similar treatments which use common levels of healthcare
resource. They enable the comparison of activity within and
between diﬀerent organisations with the National Health
Service.
National tariﬀ is the national price for each HRG for
each patient spell in hospital. There are separate tariﬀsf o r
elective and emergency care and providers are compensated
for unavoidable regional cost diﬀerences. Their use as con-
sistent “units of currency” supports standardised healthcare
commissioning across the service. The previous version of
HRGs (v3.5) has been used since 2003 but lately the Casemix
service has introduced a major revision, HRG4 [47], which
was commissioned by the Department of Health (DoH), to
support the policy of payment by results [48] (PbR) from
2009-10 for payment.
Using the most up to date HRG4 code, the cost of HRG
NZO3A (national tariﬀ for CS 19 years and over) minus
HRG cost NZO1B (national tariﬀ for normal delivery 19
years and over without complications) for each successful
version would generate an estimated savings of £1,405.00
(Table 5). The use of CNB adds approximately 30 successful
versions per 100 attempts (i.e., from 25%–30% success rate
up to 55%–60%) [45]. We can attribute 30% of this cost
saving or £42,150.00 pounds sterling directly to the CNB.
In the new HRG version 4 there is no individual cost for
epidural as this is absorbed into the cost of the maternity
eventitself.Ifweadoptaconservativeestimateof15%(asnot
all successful versions will deliver vaginally) or an additional
15 successful versions/100, the cost saving per regional block
would be £21,750.00. This is similar to results of previous
studies [44, 49].
If delivery is planned immediately after attempted ECV,
the epidural could be used for labour analgesics if the version6 Obstetrics and Gynecology International
Table 5: Delivery Event National ±PbR Tariﬀs 2008-09 & 2009-10⊥.
2008-09
HRG V3.5 Description ∗∗Cost in £
N06 Normal Delivery with CC± 996
N07 Normal Delivery without CC 996
N08 Assisted Delivery with CC 2029
N09 Assisted Delivery without CC 1422
N10 Caesarean Section with CC 3077
N11 Caesarean Section without CC 2198
2009-10
HRG V4 Description ∗∗Cost in £
NZ01A Normal delivery 19 years and over with CC 1881
NZ01B Normal delivery 19 years and over without CC 1174
NZ01C Normal delivery 18 years and under with CC 1921
NZ01D Normal delivery 18 years and under without CC 1177
NZ02A Assisted delivery with CC 2288
NZ02B Assisted delivery without CC 1728
NZ03A Caesarean Section 19 years and over 2579
NZ03B Caesarean Section 18 years and under 2654
NZ03C Caesarean Section with complications 3626
⊥ Adapted from HRG4 [41]. ±CC Complications. ∗∗Cost is expressed in pounds (£) Sterling. ±PbR Payment by Result.
is successful or for operative delivery if it fails. The later
practice would limit any additional cost attributable to the
version, particularly those related to nursing or hospital
charges which would make the cost–beneﬁt analysis even
more favourable. There is currently no incentive such as
ﬁnancial beneﬁts for units pursuing strategies to reduce
Caesarean section as the hospitals get paid for services
rendered under the PbR.
Itisanticipatedthattherewouldbeacommitmentbythe
DoH to make a proportion of providers’ income conditional
on quality and innovation, through the Commissioning for
Quality and Innovation [50] (CQUIN) payment framework.
For the acute sector, this would be through a CQUIN
scheme linking payment to speciﬁc locally determined goals.
Our trust and Yorkshire and Humber NHS organisations are
one of the front runners to sign up to delivery of a regional
set of quality indicators as the mechanism for delivering the
nationally set CQUIN policy. This option will be available in
2009/10 as an interim stage.
6. Conclusion
This systematic review compared seven randomized con-
trolled trials and found more women had successful ECV
if they received regional anaesthesia (174/339; 51.3%) than
women who did not receive anaesthesia (103/295; 34.9%).
Thuswomenreceivinganaesthesiawere1.5timesmorelikely
than women not receiving anaesthesia to have a successful
ECV (95% CI 1.22–1.77). Number needed to treat (NNT)
is 6 women needed to receive anaesthesia for 1 baby to be
turned from a breech to cephalic presentation.
It showed CNB-aided ECV as an additional tool for
women with breech-presenting fetus. When successful, it
may reduce CS in the index pregnancy and may allow for
normal deliveries in subsequent pregnancies without the risk
of trial of scar or placental accretism. A limitation of all
the trials is that relatively few women have been involved
in the randomized control trials comparing both groups; so
estimates of maternal and fetal risks with CNB cannot be
quantiﬁed. Furthermore, the obstetricians were not blinded
to the presence or absence of anaesthesia in these trials.
This is bound to inﬂuence the operators view to pursue
a successful version as well as operators own bias. In the
reports of Delisle et al. [32] and Hollard et al. [33], the
method of random allocation was not speciﬁed.
Thereisnooptimalgestationalageforwhichthismethod
could be applied. While delivery immediately following
ECV would make the cost beneﬁt analysis more favourable,
there is concern that waiting until term to attempt ECV
will potentially reduce the success rate and risk onset of
spontaneous labour which also reduces success rate or may
even be a relative contraindication to attempt ECV.
There was no information about the most important
outcome which is avoidance of C-section. Not every suc-
cessful version will deliver vaginally and some may revert
while others may require intrapartum CS as high as 16.9%
[51]. Because of conﬂicting results, the use of regional
anaesthesia for facilitating external cephalic version cannot
be recommended at this stage. A larger randomized, blinded
(which would be diﬃcult if not impossible) controlled trial
is required to evaluate the safety and success of this practice.
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